Q4 2025 Astrana Health Inc Earnings Call Transcript
Key Points
- Astrana Health Inc (ASTH) reported a record revenue of $3.2 billion for 2025, marking a 56% year-over-year growth.
- The company achieved a 50% year-over-year increase in adjusted EBITDA for the fourth quarter, reaching $52.5 million.
- Astrana Health Inc (ASTH) demonstrated strong free cash flow generation, totaling $104.5 million for the full year 2025.
- The company successfully integrated Prospect Health, achieving high provider engagement and retention rates.
- Astrana Health Inc (ASTH) continues to expand its geographic footprint, with revenue outside California growing by 90% year over year.
- Astrana Health Inc (ASTH) is facing a material weakness in internal controls over financial reporting related to acquisition and purchase accounting processes.
- The company anticipates potential headwinds from Medicaid and exchange disenrollment, which could impact revenue and cost trends.
- There is uncertainty regarding the 2027 Medicare Advantage rate update, which could affect future profitability.
- Astrana Health Inc (ASTH) is experiencing elevated medical cost trends across the industry, which may pressure margins.
- The company has embedded conservative assumptions in its 2026 guidance, reflecting potential adverse selection and rate acuity mismatches.
Good morning, everyone, and welcome to Astrana Health's fourth-quarter and year-end 2025 earnings call. (Operator Instructions) Today's speakers will be Brandon Sim, President and Chief Executive Officer of Astrana Health; and Chan Basho, Chief Operating and Financial Officer. This press release announcing Astrana Health's results for the fourth quarter and year ended December 31, 2025, is available at the Investors section of the company's website at www.astranahealth.com.
The company will discuss certain non-GAAP measures during the call. Reconciliations to the most comparable GAAP measures are included in the press release. To provide some additional background on its results, the company has made a supplemental deck available on its website. A replay of this broadcast will be available at Astrana Health's website after the conclusion of this call.
Before we get started, I'd like to remind everyone that this conference call and any accompanying information discussed herein contains forward-looking statements within
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
